관상동맥 질환 치료기기 시장 : 제품 유형별, 치료 유형별 - 세계 예측(2025-2030년)

The Coronary Artery Disease Treatment Devices Market was valued at USD 4.33 billion in 2023, expected to reach USD 4.58 billion in 2024, and is projected to grow at a CAGR of 5.75%, to USD 6.41 billion by 2030.

The Coronary Artery Disease (CAD) Treatment Devices market is specialized in developing and manufacturing devices that aid in treating CAD, such as stents, angioplasty balloons, atherectomy devices, and guiding catheters. These devices are crucial for opening narrowed or blocked coronary arteries to restore blood flow to the heart, thereby preventing heart attacks. The necessity of these devices is underscored by the rising incidence of CAD, fueled by lifestyle factors such as poor diet, lack of exercise, and smoking, coupled with an aging global population. Market applications span hospitals, cardiac care centers, and ambulatory surgical centers, and their end-use extends widely to practitioners, surgeons, and interventional cardiologists. Key growth factors influencing this market include technological advancements such as drug-eluting stents, innovative delivery systems, and robotic-assisted surgeries. Precision medicine and personalized treatment plans present lucrative opportunities, along with untapped emerging markets that provide a fertile ground for business expansion. However, challenges stymieing market growth include stringent regulatory approvals, high costs associated with advanced treatment solutions, and competition from pharmaceutical interventions. Additionally, the complexity of procedures and the necessity of skilled personnel can limit widespread adoption. Innovation should be directed towards developing next-generation stents and minimally invasive technologies that enhance patient recovery times and outcomes, as well as integrating digital health technologies to monitor patient conditions post-procedure effectively. The market is currently characterized by rapid technological progression and moderate competition, pushing companies toward constant innovation and strategic collaborations. To capitalize on market opportunities, firms should focus on expanding R&D efforts, collaborating with healthcare professionals to tailor devices for local needs, and enhancing market penetration through strategic partnerships. Staying ahead demands not only leveraging cutting-edge technologies but also adapting to regional healthcare dynamics and patient demographics to ensure that solutions are both accessible and effective.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronary Artery Disease Treatment Devices Market

The Coronary Artery Disease Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiovascular diseases
  • Increased preference for minimally invasive procedures
  • Change in lifestyle and increased psychosocial stress
• Market Restraints
  • High cost of instruments and procedures
• Market Opportunities
  • Advent of advanced technological diagnostics for the diagnosis of heart diseases
  • Increasing investments are made to cater to the rising demand for cardiovascular surgical devices
• Market Challenges
  • Low affordability and inaccessibility of cardiac surgeries in developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Coronary Artery Disease Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronary Artery Disease Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronary Artery Disease Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronary Artery Disease Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronary Artery Disease Treatment Devices Market

A detailed market share analysis in the Coronary Artery Disease Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronary Artery Disease Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronary Artery Disease Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronary Artery Disease Treatment Devices Market

A strategic analysis of the Coronary Artery Disease Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Disease Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Ge Healthcare, Hitachi, Ltd., Koninklijke Philips N.V., Medtronic PLC, MicroPort Scientific Corporation, Siemens Healthineer, Terumo Corporation, and Toshiba Corporation.

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Disease Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Coronary Guidewires, Coronary Stents, and PTCA Balloon Catheters.
• Based on Treatment Type, market is studied across Angioplasty, Cardiac Rehabilitation, and Surgery.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiovascular diseases
    • 5.1.1.2. Increased preference for minimally invasive procedures
    • 5.1.1.3. Change in lifestyle and increased psychosocial stress
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of instruments and procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Advent of advanced technological diagnostics for the diagnosis of heart diseases
    • 5.1.3.2. Increasing investments are made to cater to the rising demand for cardiovascular surgical devices
  • 5.1.4. Challenges
    • 5.1.4.1. Low affordability and inaccessibility of cardiac surgeries in developing countries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Coronary Artery Disease Treatment Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Coronary Guidewires
• 6.3. Coronary Stents
• 6.4. PTCA Balloon Catheters

7. Coronary Artery Disease Treatment Devices Market, by Treatment Type

• 7.1. Introduction
• 7.2. Angioplasty
• 7.3. Cardiac Rehabilitation
• 7.4. Surgery

8. Americas Coronary Artery Disease Treatment Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Coronary Artery Disease Treatment Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Coronary Artery Disease Treatment Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. B. Braun Melsungen AG
• 3. Becton, Dickinson and Company
• 4. Biotronik SE & Co. KG
• 5. Boston Scientific Corporation
• 6. Canon Medical Systems Corporation
• 7. FUJIFILM Holdings Corporation
• 8. Ge Healthcare
• 9. Hitachi, Ltd.
• 10. Koninklijke Philips N.V.
• 11. Medtronic PLC
• 12. MicroPort Scientific Corporation
• 13. Siemens Healthineer
• 14. Terumo Corporation
• 15. Toshiba Corporation